Nilesh Kambli, CFO of Star Health and Allied Insurance, has outlined a disciplined growth strategy for the upcoming fiscal year. Despite being the dominant player in India’s retail health insurance market, the company is signaling that it will not chase market share at the expense of its underwriting standards or financial health.
The Strategy: Disciplined Growth
Kambli’s outlook for FY27 focuses on sustainable expansion rather than aggressive, high-risk customer acquisition.
-
Premium Growth: The insurer is targeting a high single-digit increase in annual premiums for the current fiscal year.
-
Market Share: The goal is to maintain current levels or achieve marginal improvement. Kambli explicitly stated the company is “happy to give up some market share” if the alternative involves entering “risky businesses” that could hurt the bottom line.
-
Risk Mitigation: By avoiding low-margin or high-risk segments, Star Health aims to maintain its loss ratios and ensure long-term profitability—a move that aligns with the broader industry trend of prioritizing “responsible” market making, as noted by RBI Governor Malhotra earlier today.
Retail Health Context: The Market Leader’s Edge
Star Health’s cautious stance is significant because it remains the largest standalone health insurer in a sector projected to reach ₹5.4 trillion by 2030.
| Star Health’s Focus Areas | Expected Outcome |
| Retail Health Dominance | Continued focus on individual and family plans, which typically offer better margins than large group/corporate schemes. |
| Pricing Discipline | Avoiding “price wars” with newer digital-first insurers to maintain the quality of the risk pool. |
| Profitability | Ensuring that premium growth translates into actual net profit, avoiding the “valuation traps” mentioned by analysts earlier this year. |
How the Insurance Ecosystem is Evolving
This “prudence-first” approach from Star Health comes at a time of massive structural shifts in the Indian insurance landscape:
-
GST Relief: The removal of GST on retail health policies (effective September 2025) has increased affordability, giving market leaders like Star Health a natural tailwind to grow without needing to take on excessive risk.
-
Digitalization: Like its peers, Star Health is leveraging digital channels for faster claims processing and reduced operational costs.
-
Regulatory Scrutiny: With the IRDAI tightening its grip on grievance redressal and claims handling, Star Health’s focus on “non-risky business” is likely a strategic move to minimize regulatory friction and policyholder complaints.
The Bottom Line for Investors
Kambli’s comments suggest that Star Health is moving into a “consolidation and quality” phase. For investors, this is often seen as a sign of a maturing company that values dividend stability and balance sheet strength over speculative growth. While it may not see the 30-40% growth spikes of newer tech-led players, it is positioning itself as a defensive “anchor” in a volatile market.
